Published July 10, 2024 | Version v1

Evidence mapping of methods for incorporating economic considerations in clinical practice guideline development: a scoping review and document analysis protocol

  • 1. Division of Health Systems and Public Health, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, South Africa.
  • 2. Health Systems Research Unit, South African Medical Research Council, South Africa.
  • 3. Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Stellenbosch, South Africa.
  • 4. Cochrane Nigeria, University of Calabar, Nigeria.
  • 5. Department of Planning and Policy Development, Ministry of Health, Malawi.
  • 6. Evidence Informed Decision-making Centre, Department of Community and Environmental Health, School of Global and Public Health, Kamuzu University of Health Sciences, Blantyre, Malawi

Description

Background: Incorporating economic evidence in clinical guidelines enhances efficiency in healthcare systems. The underuse of high-quality economic evidence in clinical guideline development can result in inefficiencies that undermine population health. Consequently, economic dimensions have been incorporated into guideline development in recent years. Even with these advances, the process of incorporating economic evidence into clinical guidelines is unclear. Furthermore, the selection, appraisal, and synthesis of economic evidence to be included in guideline development is often inconsistent and non-systematic. Thus, we aim to examine the literature for guidance on methods, including economic evidence, in developing clinical practice guidelines and summarise these methods.

Methods: We will conduct a scoping review to examine current practices in integrating economic evidence in guideline development, guided by the framework proposed by the Joanna Briggs Institute and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis extension for scoping reviews. We will develop a search strategy using keywords and index terms related to economic evidence in guidelines. Two authors will search the relevant electronic databases and grey literature sources for methods manuals published within the last ten years. After screening the guideline manuals against the eligibility criteria, two authors will independently review the full texts to extract the data. We will use a narrative approach to describe the dominant methodological approaches and challenges identified in incorporating economic evidence in guideline development.

Conclusion: The results from this scoping review will provide an overview of the current methods for incorporating economic evidence in guideline development. This will provide guidance for guideline development groups in Malawi, Nigeria, and South Africa working on the Global Evidence, Local Adaptation project, but it may also be applicable to a broader global audience.

Files

ScR Protocol for inclusion of economic evidence in clinical guideline development_Final 10.07.24.pdf

Additional details

Funding

European Union
EDCTP2 - European Union RIA2020S-3303-GELA

Dates

Submitted
2024-07-10